ReVision Optics names Allergan, CooperVision vet Manesis as R&D veep
Dr. Manesis was most recently veep at specialty materials company Solaris Technology Group. Prior to that, he operated as veep of R&D for Allergan for 5 years, and served as chemistry and materials science director at CooperVision.
“Nick’s experience is highly relevant to our efforts to continue to advance the Raindrop Near Vision Inlay’s delivery systems as well as materials technology. Of note, his work at CooperVision and Allergan included biomaterials used in the manufacture of hydrogel contact lenses, corneal implants and other ocular lenses. The R&D function is critical to our leadership and innovation strategy, and we are delighted to have Nick’s extensive knowledge base, technical and analytical expertise to lead us in these efforts,” CEO John Kilcoyne said in prepared remarks.
“It’s exciting to join the RVO team to assist in the commercialization of this innovative approach to correcting presbyopia and to support the development of future innovative products. I look forward to being a part of the company’s entrepreneurial culture with a strong near and long term focus on the commercial success of the Raindrop,” Dr. Manesis said in a prepared statement.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.